Merit Research Development vs Gross Profit Analysis
MMSI Stock | USD 81.89 0.37 0.45% |
Merit Medical financial indicator trend analysis is infinitely more than just investigating Merit Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merit Medical Systems is a good investment. Please check the relationship between Merit Medical Research Development and its Gross Profit accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Research Development vs Gross Profit
Research Development vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merit Medical Systems Research Development account and Gross Profit. At this time, the significance of the direction appears to have totally related.
The correlation between Merit Medical's Research Development and Gross Profit is 0.99. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Merit Medical Systems, assuming nothing else is changed. The correlation between historical values of Merit Medical's Research Development and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Merit Medical Systems are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Research Development i.e., Merit Medical's Research Development and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.99 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Research Development
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Merit Medical Systems minus its cost of goods sold. It is profit before Merit Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Merit Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. As of now, Merit Medical's Enterprise Value is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 406.9M | 418.0M | 400.3M | 420.3M | Cost Of Revenue | 589.4M | 631.9M | 731.1M | 767.6M |
Merit Medical fundamental ratios Correlations
Click cells to compare fundamentals
Merit Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merit Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 1.7B | 1.6B | 1.7B | 2.3B | 2.4B | |
Short Long Term Debt Total | 523.7M | 435.1M | 315.0M | 268.8M | 891.4M | 935.9M | |
Other Current Liab | 108.0M | 114.8M | 161.6M | 129.9M | 120.4M | 126.5M | |
Total Current Liabilities | 181.7M | 185.0M | 236.3M | 220.6M | 203.6M | 213.7M | |
Total Stockholder Equity | 949.9M | 958.6M | 1.0B | 1.1B | 1.2B | 1.3B | |
Property Plant And Equipment Net | 459.0M | 461.0M | 437.6M | 448.2M | 446.6M | 468.9M | |
Net Debt | 479.4M | 378.2M | 247.3M | 210.3M | 302.2M | 317.3M | |
Retained Earnings | 368.2M | 357.8M | 406.3M | 480.8M | 575.2M | 603.9M | |
Non Current Assets Total | 1.3B | 1.2B | 1.2B | 1.1B | 1.2B | 1.3B | |
Net Receivables | 168.5M | 158.0M | 172.8M | 178.4M | 189.3M | 198.7M | |
Common Stock Shares Outstanding | 56.2M | 55.4M | 57.4M | 57.7M | 58.4M | 39.5M | |
Liabilities And Stockholders Equity | 1.8B | 1.7B | 1.6B | 1.7B | 2.3B | 2.4B | |
Non Current Liabilities Total | 625.7M | 520.8M | 372.2M | 298.9M | 919.7M | 965.7M | |
Inventory | 225.7M | 198.0M | 221.9M | 266.0M | 303.9M | 319.1M | |
Other Current Assets | 12.5M | 13.1M | 16.1M | 22.3M | 26.2M | 27.5M | |
Other Stockholder Equity | (294K) | (5.5M) | (8.0M) | (11.6M) | (10.4M) | (9.9M) | |
Total Liab | 807.4M | 705.8M | 608.5M | 519.6M | 1.1B | 1.2B | |
Property Plant And Equipment Gross | 459.0M | 461.0M | 652.3M | 686.2M | 775.6M | 814.4M | |
Total Current Assets | 454.5M | 429.7M | 482.2M | 529.1M | 1.1B | 1.2B | |
Accumulated Other Comprehensive Income | (5.3M) | (5.5M) | (8.0M) | (11.6M) | (11.3M) | (10.8M) | |
Short Term Debt | 19.1M | 20.4M | 19.1M | 22.3M | 12.1M | 9.2M | |
Intangible Assets | 445.3M | 367.9M | 319.3M | 275.9M | 325.9M | 342.2M | |
Cash | 44.3M | 56.9M | 67.8M | 58.4M | 589.1M | 618.6M | |
Cash And Short Term Investments | 44.3M | 56.9M | 67.8M | 58.4M | 589.1M | 618.6M | |
Accounts Payable | 54.6M | 49.8M | 55.6M | 68.5M | 65.9M | 69.2M | |
Non Currrent Assets Other | 24.3M | 25.6M | 26.7M | 28.8M | 32.3M | 33.9M | |
Common Stock Total Equity | 587.0M | 606.2M | 641.5M | 675.2M | 776.5M | 815.3M | |
Common Stock | 587.0M | 606.2M | 641.5M | 675.2M | 638.2M | 670.1M | |
Other Liab | 120.7M | 102.7M | 76.3M | 52.4M | 60.3M | 35.4M | |
Other Assets | 28.1M | 227.7M | 47.5M | 31.9M | 36.7M | 25.7M | |
Long Term Debt | 432.0M | 343.7M | 234.4M | 186.8M | 823.0M | 864.2M | |
Good Will | 353.2M | 363.5M | 361.7M | 359.8M | 382.2M | 401.4M | |
Property Plant Equipment | 459.0M | 382.7M | 437.6M | 383.0M | 440.4M | 462.4M | |
Net Tangible Assets | 151.4M | 227.1M | 358.8M | 508.7M | 585.0M | 614.3M | |
Long Term Debt Total | 432.0M | 343.7M | 234.4M | 186.8M | 214.8M | 281.4M | |
Long Term Investments | 17.1M | 12.0M | 14.7M | 15.6M | 19.1M | 12.1M |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.333 | Earnings Share 1.74 | Revenue Per Share 22.224 | Quarterly Revenue Growth 0.087 | Return On Assets 0.0425 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.